RLYB: Rallybio Corp. Company Aggregate Debts

Symbol and logo of brand rallybio.com (RLYB)

The debt capital history of Rallybio Corporation (RLYB) demonstrates the dynamics of its liabilities, while the 0.00 metric indicates the status of its debt load. Rallybio Corporation (RLYB) focuses on developing advanced antibodies to combat neonatal and fetal pathologies. However, geopolitical instability may restrict the logistics of biomaterials, and the asset's market value depends primarily on clinical trial results rather than macroeconomics.

RLYB: Rallybio Corp Company Debts 07/04/2022 - 10/30/2026
Signature product of Rallybio

The financial stability assessment of Rallybio Corporation (RLYB) is based on the aggregate debt burden, which reflects the actual volume of borrowed funds via the daily market consensus for solvency analysis. The trend in leverage levels confirms the business's margin of safety, allowing the company to invest in retaining key biologists and hiring leading regulatory experts without the risk of a capital shortfall.

Who Rallybio Corporation competes with

HLN (Haleon Corp) - Aggregate Debt Obligations|Company Aggregate Debts KVUE (Kenvue Inc.)|Company Aggregate Debts veronapharma.com VRNA|MENS - Company Debts|Aggregate Debt Obligations LGND (Ligand Pharmaceuticals Incorporated)|Amneal Pharmaceuticals Inc (AMRX) - Company Debts|Company Total Debt Perrigo Corp|ALVO (Alvotech) - Company Aggregate Debts|Company Aggregate Debts liquidia.com|Company Total Debt GLPG (Galapagos)|ANIP (ANI Pharmaceuticals Inc) - Aggregate Debt Obligations|Company Debts MannKind Corp. MNKD|Amphastar Corp (AMPH) - Company Cumulative Debt|PCRX: Company Total Debt|ars-pharma.com - Company Cumulative Indebtedness|TBPH: Company Aggregate Debts|Aquestive Therapeutics Inc - Aggregate Debt Obligations|SCPH (scPharmaceuticals, Inc.) - Company Aggregate Debts|Company Cumulative Debt Tectonic TECX|Company Debts Tonix Pharmaceuticals (TNXP)|SXTC (sxtchina.com) - Aggregate Debt Obligations|Company Debts Eupraxia Pharmaceuticals Inc. EPRX|Aggregate Debt Obligations BHST|Invizyne Technologies, Inc. - Company Aggregate Debts|ORMP - Company Aggregate Debts|enterabio.com (ENTX) - Company Debts|HYFT (ipatherapeutics.com) - Company Debts|Company Debts ABVC BioPharma, Inc.|Company Debts CPIX|Company Total Debt QNTM (Quantum BioPharma Limited)|FGEN - Company Cumulative Debt|Company Aggregate Debts TELO (Telomir Pharmaceuticals)|Rani Therapeutics Holdings - Company Debts|Synergy CHC Corporation - Company Aggregate Debts|Company Total Debt Obligations Lexaria Bioscience LEXX|Pulmatrix Corp (PULM) - Company Debts|Company Cumulative Debt Pheton Holdings (PTHL)|Company Total Debt APM|LYRA: Aggregate Debt Obligations|Company Aggregate Debts IBO|Company Total Debt tnfpharma.com TNFA|Company Debts cbdMD YCBD|PainReform Corp (PRFX) - Company Cumulative Debt|CYTO - Company Debts|Aggregate Debt Obligations LIPO (lipella.com)|OptiNose (OPTN) - Company Debts|Company Aggregate Indebtedness PIRS (Pieris Pharmaceuticals Inc)|Company Debts Procaps Group SA|Company Cumulative Debt Petros Pharma PTPI|Company Debts Qilian International (QLI)|SLRN (acelyrin.com) - Aggregate Debt Obligations|Company Aggregate Debts TFFP (TFF Pharmaceuticals, Inc.)